Quick Answer
Xtant Medical Holdings, Inc. reported Gross Profit of $84.27 million for the year ending 2025.
- Xtant Medical Holdings, Inc. showed an increase of +23.5% in Gross Profit from 2024 to 2025.
- This data is from Xtant Medical Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $2.68 million | Q3 2010: $3.48 million | Q1 2011: $5.01 million | Q2 2011: $5.77 million | Q3 2011: $6.22 million | Q1 2012: $5.91 million | Q2 2012: $5.88 million | Q3 2012: $6.28 million | Q1 2013: $5.50 million | Q2 2013: $4.69 million | Q3 2013: $4.61 million | Q1 2014: $5.50 million | Q2 2014: $5.59 million | Q3 2014: $5.44 million | Q1 2015: $6.03 million | Q2 2015: $6.52 million | Q3 2015: $11.66 million | Q1 2016: $14.10 million | Q2 2016: $14.70 million | Q3 2016: $15.98 million | Q1 2017: $14.91 million | Q2 2017: $13.53 million | Q3 2017: $11.37 million | Q1 2018: $12.23 million | Q2 2018: $12.48 million | Q3 2018: $11.52 million | Q1 2019: $10.81 million | Q2 2019: $9.91 million | Q3 2019: $10.41 million | Q1 2020: $9.61 million | Q2 2020: $6.55 million | Q3 2020: $9.25 million | Q1 2021: $8.09 million | Q2 2021: $9.52 million | Q3 2021: $7.19 million | Q1 2022: $7.56 million | Q2 2022: $8.37 million | Q3 2022: $7.90 million | Q1 2023: $10.54 million | Q2 2023: $12.46 million | Q3 2023: $15.33 million | Q1 2024: $17.30 million | Q2 2024: $18.58 million | Q3 2024: $16.31 million | Q1 2025: $20.24 million | Q2 2025: $24.28 million | Q3 2025: $21.99 million.
- Over the full 16 years of available data (2010 to 2025), Xtant Medical Holdings, Inc.'s Gross Profit has grown by 599.1%.
- Historical annual values: Fiscal year 2025: $84.27 million | Fiscal year 2024: $68.22 million | Fiscal year 2023: $55.47 million | Fiscal year 2022: $32.14 million | Fiscal year 2021: $32.49 million | Fiscal year 2020: $34.39 million | Fiscal year 2019: $42.52 million | Fiscal year 2018: $43.49 million | Fiscal year 2017: $50.10 million | Fiscal year 2016: $62.29 million | Fiscal year 2015: $39.08 million | Fiscal year 2014: $22.30 million | Fiscal year 2013: $18.89 million | Fiscal year 2012: $22.64 million | Fiscal year 2011: $21.04 million | Fiscal year 2010: $12.05 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: